हमारा समूह 1000 से अधिक वैज्ञानिक सोसायटी के सहयोग से हर साल संयुक्त राज्य अमेरिका, यूरोप और एशिया में 3000+ वैश्विक सम्मेलन श्रृंखला कार्यक्रम आयोजित करता है और 700+ ओपन एक्सेस जर्नल प्रकाशित करता है जिसमें 50000 से अधिक प्रतिष्ठित व्यक्तित्व, प्रतिष्ठित वैज्ञानिक संपादकीय बोर्ड के सदस्यों के रूप में शामिल होते हैं।
ओपन एक्सेस जर्नल्स को अधिक पाठक और उद्धरण मिल रहे हैं
700 जर्नल और 15,000,000 पाठक प्रत्येक जर्नल को 25,000+ पाठक मिल रहे हैं
Placide Mbala Serra
Post-exposure prophylaxis (PEP) is a preventive treatment strategy used to reduce the risk of acquiring an infection after potential exposure to a specific pathogen. PEP is commonly employed in situations involving recent exposure to HIV, although it can also be utilized for other infections such as hepatitis B and C. The effectiveness of PEP depends on various factors, including the type of infection, the timing of initiation, and adherence to the prescribed regimen. Prompt administration of PEP within 72 hours (preferably within 24-48 hours) of exposure is crucial for optimal effectiveness. PEP for HIV typically involves a 28-day course of antiretroviral medications to inhibit viral replication and decrease the likelihood of establishing a permanent infection. However, it is important to note that PEP is not 100% effective and its success varies depending on multiple factors. While PEP can significantly reduce the risk of HIV transmission, it is not a substitute for regular preventive measures such as safe sex practices, condom usage, and pre-exposure prophylaxis (PrEP) for high-risk individuals. PEP can also be considered for potential exposure to hepatitis B and, in certain specific cases, hepatitis C. Healthcare providers play a critical role in assessing the risk of infection, evaluating the appropriateness of PEP, and providing guidance on the correct use of medications. Timely medical attention and open communication with healthcare professionals are vital in ensuring the most effective outcomes of PEP and minimizing the risk of infection.